ArticleThoracic cancer2020

M2 macrophages reduce the effect of gefitinib by activating AKT/mTOR in gefitinib-resistant cell lines HCC827/GR.

Fengqi Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.